• Markets
  • icon
  • Companies
MYX · ASX

Mayne Pharma Group Ltd. (ASX:MYX)

AU$6.66

 -0.09 (-1.333%)
ASX:Live
19/04/2024 04:10:42 PM
HALO Small HALO Ords HALO Momentum HALO Growth HALO Balance Sheet +3
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

MYX Overview

MYX Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Very Strong

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About MYX

Telephone

Address

Description

Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.

MYX Price Chart

Key Stats

Market Cap

AU$574.25M

PE

0.00

EV/EBITDA

0.0

Dividends Overview

DIV Yield

.6%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.75 - 7.4

Trade Value (12mth)

AU$328,273.00

1 week

-5.67%

1 month

-4.86%

YTD

9.36%

1 year

76.66%

All time high

37.0985

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

-65.90%

Operating Cashflow

-$43m

Free Cash Flow Return

-7.00%

ROIC

-51.30%

Interest Coverage

-11.60

Quick Ratio

1.50

Other Data

Shares on Issue (Fully Dilluted)

81m

HALO Sector

Next Company Report Date

23-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.70

MYX Announcements

Latest Announcements

Date Announcements

05 April 24

Notification of cessation of securities - MYX

×

Notification of cessation of securities - MYX

26 March 24

Notification regarding unquoted securities - MYX

×

Notification regarding unquoted securities - MYX

26 March 24

Notification of cessation of securities - MYX

×

Notification of cessation of securities - MYX

18 March 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

12 March 24

Becoming a substantial holder

×

Becoming a substantial holder

11 March 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

05 March 24

Becoming a substantial holder

×

Becoming a substantial holder

28 February 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

27 February 24

Becoming a substantial holder

×

Becoming a substantial holder

26 February 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

26 February 24

2024 Half Year Media Release

×

2024 Half Year Media Release

26 February 24

2024 Half Year Investor Presentation

×

2024 Half Year Investor Presentation

12 February 24

Notification of date for release of 1H24 results

×

Notification of date for release of 1H24 results

12 February 24

Notification of date for release of 1H24 results

×

Notification of date for release of 1H24 results

11 January 24

Mayne Pharma presentation at JP Morgan Healthcare Conference

×

Mayne Pharma presentation at JP Morgan Healthcare Conference

04 January 24

Notification regarding unquoted securities - MYX

×

Notification regarding unquoted securities - MYX

02 January 24

Mayne Pharma to present at JP Morgan Healthcare Conference

×

Mayne Pharma to present at JP Morgan Healthcare Conference

22 December 23

Update - Notification of buy-back - MYX

×

Update - Notification of buy-back - MYX

21 December 23

Update - Notification of buy-back - MYX

×

Update - Notification of buy-back - MYX

20 December 23

Update - Notification of buy-back - MYX

×

Update - Notification of buy-back - MYX

19 December 23

Update - Notification of buy-back - MYX

×

Update - Notification of buy-back - MYX

18 December 23

Update - Notification of buy-back - MYX

×

Update - Notification of buy-back - MYX

15 December 23

Becoming a substantial holder

×

Becoming a substantial holder

15 December 23

Update - Notification of buy-back - MYX

×

Update - Notification of buy-back - MYX

14 December 23

Update - Notification of buy-back - MYX

×

Update - Notification of buy-back - MYX

MYX Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock N/A -3.20 -3.85 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock N/A -3.20 -3.67 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A -20.3 Lock Lock Lock
     PE X Lock Lock Lock Lock 148.9 N/A 0.0 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 12.2 N/A 0.0 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.69 0.12 -2.26 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock N/A -0.32 -1.12 Lock Lock Lock
     Growth % Lock Lock Lock Lock 16.7 -83.2 -2,055.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A -6.5 -25.5 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 N/A 0.6 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 8.71 6.40 7.60 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 1.50 1.56 0.20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 67.1 3.8 -86.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock N/A 82 86 Lock Lock Lock
Basic m Lock Lock Lock Lock N/A 82 82 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 401 425 184 Lock Lock Lock
     Growth % Lock Lock Lock Lock -12.3 6.0 -56.8 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 126 168 213 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 127 105 27 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.9 -17.1 -74.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 31.7 24.8 14.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 68 75 85 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 70 19 -121 Lock Lock Lock
     Growth % Lock Lock Lock Lock -4.0 -73.1 -746.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 17.4 4.4 -65.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 68 81 65 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 1 -62 -186 Lock Lock Lock
     Growth % Lock Lock Lock Lock 111.2 -4,675.3 -199.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.3 -14.7 -101.6 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -264 -218 -270 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -55 56 48 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -208 -263 -316 Lock Lock Lock
     Growth % Lock Lock Lock Lock -124.6 -26.4 -20.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -52.0 -62.0 -172.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 47 -17 -43 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 25 12 220 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -49 -29 473 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -29 37 -431 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 30 -27 -51 Lock Lock Lock
     Growth % Lock Lock Lock Lock -66.8 -188.3 -93.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.1 -0.1 -0.3 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 21 22 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 98 97 229 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 1,478 1,303 1,248 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 293 6 33 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 248 317 -182 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 707 746 614 Lock Lock Lock
Equity $m Lock Lock Lock Lock 768 565 634 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 1,061 570 667 Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.7 -46.2 17.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -14.1 -20.2 -25.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -27.1 -46.6 -49.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 0.1 -6.0 -22.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -17.0 -32.3 -51.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 3.9 -2.0 -7.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 5.2 1.6 -11.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.6 16.9 1.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 32.3 56.1 -28.6 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.9 0.8 1.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.4 0.7 1.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 23.6 19.0 41.4 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 21.2 -2.7 -13.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 1.9 1.8 0.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 2.8 3.0 1.6 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.1 N/A 0.8 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 10.6 15.0 17.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.3 0.3 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.3 0.3 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -65.8 -51.3 -146.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -17.9 -16.7 -21.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -14.1 -20.2 -25.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.9 2.3 2.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -27.1 -46.6 -49.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -27.1 -46.6 -49.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 131.0 120.8 223.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 194.3 204.7 489.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 325.3 325.4 712.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 46.7 59.3 133.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 278.6 266.1 579.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.6%

Franking Level

100%

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.70%

Value ($M)

4

Prior Change

N/A

7 Day Change

-0.10%

1 Month Change

-0.20%

3 Month Change

-0.80%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

MYX Shortsell

Frequently Asked Questions

The current share price of Mayne Pharma Group Ltd. (MYX:ASX) is AU$6.66.
The 52-week high share price for Mayne Pharma Group Ltd. (MYX:ASX) is AU$7.40.
The 52-week low share price for Mayne Pharma Group Ltd. (MYX:ASX)? is AU$2.75.
The current TTM dividend payout for Mayne Pharma Group Ltd. (MYX:ASX) is 0.60.
The last dividend payment of Mayne Pharma Group Ltd. (MYX:ASX) is AU$1.03.
Mayne Pharma Group Ltd. (MYX:ASX) has a franking level of 100%.
Mayne Pharma Group Ltd. (MYX:ASX) is classified in the Healthcare.
The current P/E ratio for Mayne Pharma Group Ltd. (MYX:ASX) is 0.00.